![]() |
Name |
6-Oxocativic acid
|
Molecular Formula | C20H32O3 | |
IUPAC Name* |
(3S)-5-[(1S,8aR)-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1H-naphthalen-1-yl]-3-methylpentanoic acid
|
|
SMILES |
CC1=CC(=O)C2[C@@]([C@H]1CC[C@H](C)CC(=O)O)(CCCC2(C)C)C
|
|
InChI |
InChI=1S/C20H32O3/c1-13(11-17(22)23)7-8-15-14(2)12-16(21)18-19(3,4)9-6-10-20(15,18)5/h12-13,15,18H,6-11H2,1-5H3,(H,22,23)/t13-,15-,18?,20+/m0/s1
|
|
InChIKey |
JJGYRVZPUJUFTR-DRWSLCSESA-N
|
|
Synonyms |
6-Oxocativic acid; MEGxp0_000174; ACon0_000172; ACon1_000274; CHEBI:182713; NCGC00180720-01; NCGC00180720-03; (3S)-5-[(1S,8aR)-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1H-naphthalen-1-yl]-3-methylpentanoic acid; NCGC00180720-03_C20H32O3_1-Naphthalenepentanoic acid, 1,4,4a,5,6,7,8,8a-octahydro-beta,2,5,5,8a-pentamethyl-4-oxo-, (betaS,1S,8aR)-
|
|
CAS | NA | |
PubChem CID | 23843920 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 320.5 | ALogp: | 4.9 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 54.4 | Aromatic Rings: | 2 |
Heavy Atoms: | 23 | QED Weighted: | 0.753 |
Caco-2 Permeability: | -5.318 | MDCK Permeability: | 0.00002200 |
Pgp-inhibitor: | 0.13 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.809 |
30% Bioavailability (F30%): | 0.044 |
Blood-Brain-Barrier Penetration (BBB): | 0.368 | Plasma Protein Binding (PPB): | 90.36% |
Volume Distribution (VD): | 0.372 | Fu: | 6.09% |
CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.228 |
CYP2C19-inhibitor: | 0.028 | CYP2C19-substrate: | 0.804 |
CYP2C9-inhibitor: | 0.317 | CYP2C9-substrate: | 0.981 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.131 |
CYP3A4-inhibitor: | 0.049 | CYP3A4-substrate: | 0.118 |
Clearance (CL): | 13.724 | Half-life (T1/2): | 0.369 |
hERG Blockers: | 0.003 | Human Hepatotoxicity (H-HT): | 0.236 |
Drug-inuced Liver Injury (DILI): | 0.318 | AMES Toxicity: | 0.04 |
Rat Oral Acute Toxicity: | 0.176 | Maximum Recommended Daily Dose: | 0.129 |
Skin Sensitization: | 0.765 | Carcinogencity: | 0.147 |
Eye Corrosion: | 0.967 | Eye Irritation: | 0.256 |
Respiratory Toxicity: | 0.956 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001350 | ![]() |
0.377 | D01CKY | ![]() |
0.262 | ||
ENC001193 | ![]() |
0.365 | D04GJN | ![]() |
0.252 | ||
ENC005922 | ![]() |
0.363 | D04ATM | ![]() |
0.250 | ||
ENC003774 | ![]() |
0.353 | D0M4WA | ![]() |
0.243 | ||
ENC005458 | ![]() |
0.353 | D0D2TN | ![]() |
0.241 | ||
ENC003754 | ![]() |
0.337 | D04SFH | ![]() |
0.240 | ||
ENC005585 | ![]() |
0.333 | D0I2SD | ![]() |
0.240 | ||
ENC002923 | ![]() |
0.333 | D07BSQ | ![]() |
0.238 | ||
ENC003214 | ![]() |
0.323 | D0F1UL | ![]() |
0.238 | ||
ENC004836 | ![]() |
0.321 | D06AEO | ![]() |
0.234 |